Evaluation of RC28-E Injection in Diabetic Macular Edema

Clinical trial NCT04782115 · COMPLETED

Trial details

NCT number: NCT04782115
Sponsor: RemeGen Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2021-03-17
Primary completion: 2023-07-31
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.